Distinguished colleagues, esteemed guests, and partners across Asia and beyond,

It is an honour and privilege to welcome you to the 17th Annual Meeting of the Asian Cellular Therapy Organization (ACTO), taking place in Jakarta, Indonesia, on August 26–28, 2026. This year marks a pivotal moment for our region as we work collectively to accelerate the growth of and strengthen Asia’s leadership in the global cellular therapy landscape.

Our theme, “Advancing Research & Clinical Translation of Cell-Based Therapies: Academician, Business, Community, and Government,” reflects ACTO’s commitment to bridging discovery, policy, clinical application, and societal impact. ACTO remains the platform where science meets regulation, innovation meets clinical need, and collaboration evolves into real-world solutions.

As a clinician, I witness the urgent need for safe, effective, and accessible cell therapies daily. ACTO 2026 is designed to to bring us closer to meeting those needs by convening researchers, clinicians, policymakers, and industry leaders in a shared space for knowledge exchange and strategic dialogue.

The discussions and interactions throughout this meeting aim to spark new insights, strengthen regional collaboration, and open pathways for advancing cell-based therapies across the Asia region. Over the course of three days, ACTO 2026 will feature high-level scientific exchanges, in-depth regulatory conversations, and opportunities to explore innovations emerging from academia and industry alike. Participants will also have the chance to engage in laboratory visits that connect scientific progress with its practical implementation and further reinforce the multidisciplinary spirit that defines ACTO.

We cordially invite you to be part of this momentum. Your perspectives, experience, and collaboration will shape meaningful progress for patients and communities across the region. On behalf of the organizing committee, I look forward to welcoming you to ACTO 2026 in Jakarta.

Sincerely,

Prof. dr. Amin Soebandrio WK, Ph.D., SpMK(K)

President of the 2026 Asian Cellular Therapy Organization (ACTO) Annual Meeting